Chinese pharmaceutical and medical device firm WuXi AppTec has acquired Pharmapace, Inc., a US-based clinical research services company that provides biometrics services for all phases of clinical trials, regulatory submissions, and post-marketing support, according to a statement released on Monday.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?